Click on the "Selected Dataset" orange button to begin data extraction procedure for your expression dataset. Output is given as three files :
| Organism | Platform Type | Selected Dataset | Description of experiment | Medline | Documentation file |
Human 642 | AFFY 479 | | Oligonucleotide array data for tumor and normal colon tissues | 10359783 | A0001_DOC |
| Molecular Classification of Human Carcinomas | 11606367 | AFFY004_DOC |
| Osteosarcoma TE85 cell tissue culture study | | GSE1000_DOC |
| Molecular profiles (HG-U95A) of dystrophin-deficient and normal human muscle | 12415109 | GSE1004_DOC |
| Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | | GSE10072_DOC |
| Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007A_DOC |
| Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007B_DOC |
| Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007C_DOC |
| Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007D_DOC |
| Diabetic nephropathy | 15042541 | GSE1009_DOC |
| FCHL study | | GSE1010_DOC |
| Acute Quadriplegic Myopathy | | GSE1017_DOC |
| Hemin timecourse 0-72h | 15252187 | GSE1036_DOC |
| Estradiol Treated Breast Cancer Cells Expressing Mutant Estrogen Receptors | 15023342 | GSE1045_DOC |
| Hypoxia and Hypoxia mimics | 15942021 | GSE1056_DOC |
| Myometrial cells expressing CREB, CREM alpha, CREM tau2alpha, ATF2 or the ATF2-small gene | 15691874 | GSE1059_DOC |
| Effect of a 4 hour treatment of 100 nM endothelin-1 on human primary lung fibroblasts | 15044479 | GSE1081_DOC |
| Emphysema Lung Tissue Gene Expression Profiling | 15284076 | GSE1122_DOC |
| Comparison between uncomplicated and severe malaria and between both and health | | GSE1124_DOC |
| IFN-Gamma keratinocytes | 15145801 | GSE1132A_DOC |
| IFN-Gamma keratinocytes | 15145801 | GSE1132B_DOC |
| tissue-specific pattern of mRNA expression | 15075390 | GSE1133A_DOC |
| PMBCs and the effect of exercise | 15194674 | GSE1140_DOC |
| Inflammatory bowel disease (HG-U133A) | | GSE1141_DOC |
| Inflammatory bowel disease (HG-U133B) | | GSE1142_DOC |
| aging of cultured human myotubes | | GSE1144_DOC |
| changes in cardiac transcription profiles brought about by heart failure | | GSE1145A_DOC |
| changes in cardiac transcription profiles brought about by heart failure | | GSE1145B_DOC |
| Sex Specific Transciption in Human Hypothalamus | | GSE1147_DOC |
| Inflammatory bowel disease | | GSE1152A_DOC |
| Inflammatory bowel disease | | GSE1152B_DOC |
| Estrogen-regulated gene expression in human osteosarcoma cells stably transfected with estrogen receptor alpha or beta | 15033914 | GSE1153_DOC |
| Wilms tumor versus Stratagene Universal Reference | | GSE1158_DOC |
| Expression profiles of acute myeloid leukemia patient samples | 15084694 | GSE1159_DOC |
| Type 2 diabetes and insulin resistance | 12436343 | GSE121A_DOC |
| Type 2 diabetes and insulin resistance | 12436343 | GSE121B_DOC |
| Type 2 diabetes and insulin resistance | 12436343 | GSE121C_DOC |
| Type 2 diabetes and insulin resistance | 12436343 | GSE121D_DOC |
| Type 2 diabetes and insulin resistance | 12436343 | GSE121E_DOC |
| Sindbis survivors | | GSE1264_DOC |
| HGPC, in monolayer, 0.5 vs. 20% serum | 15094393 | GSE1277_DOC |
| HGPC, in monolayer, 0.5% serum | 15094393 | GSE1278_DOC |
| STRRIDE Study | 15347626 | GSE1295A_DOC |
| STRRIDE Study | 15347626 | GSE1295B_DOC |
| Simple ambient preservation of human tissues for RNA expression array analysis | 15537428 | GSE1296_DOC |
| Incipient Alzheimer's Disease: Microarray Correlation Analyses | 14769913 | GSE1297_DOC |
| Breast Cancer Cell Line Experiment | 15161944 | GSE1299A_DOC |
| Breast Cancer Cell Line Experiment | 15161944 | GSE1299B_DOC |
| Breast Cancer Cell Line Experiment | 15161944 | GSE1299C_DOC |
| Hereditary Spastic Paraparesis | | GSE1300_DOC |
| primary trophoblast study | 15161964 | GSE1302A_DOC |
| primary trophoblast study | 15161964 | GSE1302B_DOC |
| primary trophoblast study | 15161964 | GSE1302C_DOC |
| primary trophoblast study | 15161964 | GSE1302D_DOC |
| primary trophoblast study | 15161964 | GSE1302E_DOC |
| Gene expession profiles for monoclonal cell lines with high or low levels of store-operated Ca2+ entry. | 15623568 | GSE1309_DOC |
| Ultraviolet induced gene expression in human basal cell culture | | GSE1317_DOC |
| Myb specificity determinants | 15105423 | GSE1318A_DOC |
| Myb specificity determinants | 15105423 | GSE1318B_DOC |
| Isogenic primary tumor/metastasis comparison | 16531451 | GSE1323_DOC |
| Burn/Trauma Study | 15548831 | GSE1343_DOC |
| Pre-analytical changes of mRNA Gene Expression as the result from prolonged storage | 15238145 | GSE1347_DOC |
| Long-Term Storage of Human Cells at Ambient Temperature | 16155929 | GSE1364_DOC |
| Kaposi's sarcoma-associated herpes virus | 15220917 | GSE1377_DOC |
| Trisomy 21 and TS13 | 16420667 | GSE1397_DOC |
| MCF-7 Fractionated RNA | 15574777 | GSE1400_DOC |
| Juvenile Rheumatoid Arthritis Profiles In PBMC and SFMC | 15150433 | GSE1402_DOC |
| Cyclosporine A timecourse 0, 12, 48 hours | 16049326 | GSE1403_DOC |
| HIV-based vector infected cells | 15314653 | GSE1407_DOC |
| ASLV vector infected 293t-TVA cells | | GSE1410_DOC |
| Untreated vs. Camptothecin Treated HeLa cells | 15026349 | GSE1417_DOC |
| Imatinib effects on CD34+ cells | 15618956 | GSE1418_DOC |
| Barrett's esophagus, Barrett's-associated adenocarcinomas and normal esophageal epithelium | 15833844 | GSE1420_DOC |
| Expression profiles in Blast Bank samples with AML/RAEB | | GSE1427A_DOC |
| Expression profiles in Blast Bank samples with AML/RAEB | | GSE1427B_DOC |
| Skeletal muscle sarcopenia | 15687482 | GSE1428_DOC |
| Human prostate cancer tissues analyses | | GSE1431_DOC |
| Transcriptional Response of Human Microglial Cells to Interferon-gamma | 16163375 | GSE1432_DOC |
| Two week Storage and Rehydration of HEK 293 Cells at Ambient Temperature | 16155929 | GSE1455_DOC |
| Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456A_DOC |
| Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456B_DOC |
| Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460A_DOC |
| Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460B_DOC |
| Mitochondrial disorders | 15728662 | GSE1462_DOC |
| Expression profiles of ATL patients | | GSE1466A_DOC |
| Expression profiles of ATL patients | | GSE1466B_DOC |
| A549 lung pneumocytes cell line infected with wildtype and deletion mutation PAK strain Pseudomonas aeruginosa | 16207250 | GSE1469_DOC |
| Epithelial stem cells co-cultured with the dermal papilla | 15292489 | GSE1470_DOC |
| Beta-catenin/GFP | | GSE1473_DOC |
| Caco-2 and T84 cells stimulated with with flagellin, lymphotox beta or TNF alpha | | GSE1474_DOC |
| LCCS vs control comparison | 16155903 | GSE1481_DOC |
| Natural variation in human gene expression | 15269782 | GSE1485_DOC |
| Hematopoietic stem cell subsets | 15790771 | GSE1493_DOC |
| Human endothelium exposed to shear stress and pressure | 16155357 | GSE1518_DOC |
| A549 parenchymal cell activation | 15454581 | GSE1541_DOC |
| Expression profile of pancreatic ductal cells | 16053509 | GSE1542A_DOC |
| Expression profile of pancreatic ductal cells | 16053509 | GSE1542B_DOC |
| dermatomyositis | 15852401 | GSE1551_DOC |
| EORTC 10994 clinical trial | 15897907 | GSE1561_DOC |
| Adenovirus-mediated E2F-1 gene transfer in melanoma cell line | 15656974 | GSE1562_DOC |
| Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes | 15307835 | GSE1563_DOC |
| Gene regulation and DNA damage in the aging human brain | 15190254 | GSE1572_DOC |
| T-ALL and T-lymphoblastic lymphoma | 16358311 | GSE1577_DOC |
| Human bladder smooth muscle cells - effect of stretch in vitro | 15467014 | GSE1595_DOC |
| Caco-2 differentiation | 12644633 | GSE1614_DOC |
| Theca cell gene expression | 15598877 | GSE1615A_DOC |
| Theca cell gene expression | 15598877 | GSE1615B_DOC |
| Carious versus healthy pulp gene expression | 15869869 | GSE1629_DOC |
| Normal Variance of Gene Expression in the Human Lung | 16498083 | GSE1643_DOC |
| Leukotriene D4-triggered Transcriptome | 15322539 | GSE1644_DOC |
| Osmotic Loading of Human Intervertebral Disc Cells | | GSE1648_DOC |
| COPD Study | 15374838 | GSE1650_DOC |
| Adipocyte Differentiation | | GSE1657A_DOC |
| Adipocyte Differentiation | | GSE1657B_DOC |
| DNA damage response (NCS treatment) in several siRNA-manipulated cellular systems | 15892871 | GSE1676_DOC |
| Global gene expression analysis of human glioma (Hs 683) cell lines exposed to candoxin | 16309724 | GSE1682_DOC |
| T98G growth arrest | 15525513 | GSE1692_DOC |
| Determination of mRNA transcripts in HeLa cells that are regulated by RENT1 | 15448691 | GSE1703_DOC |
| STS107 T-cell activation at 1g vs. vg | 16210397 | GSE1709_DOC |
| Macular Degeneration | | GSE1719_DOC |
| TGFbeta lung fibroblasts | | GSE1724_DOC |
| Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage | 15096622 | GSE1725_DOC |
| Gene expression profile of acute myeloid leukemia | 15674361 | GSE1729_DOC |
| SARS | | GSE1739_DOC |
| Tassiulas IFN Array v1.0 | 15467722 | GSE1740_DOC |
| De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function | | GSE1743_DOC |
| CD14+ cell analysis | | GSE1746_DOC |
| Human blood expression for Huntington's disease versus control | 16043692 | GSE1751_DOC |
| Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764A_DOC |
| Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764B_DOC |
| Vastus lateralis biopsies from healthy trained and sedentary males | 16260967 | GSE1786_DOC |
| heart gene expression in Down syndrome | | GSE1789_DOC |
| Melanoma progression model: Differential Gene Expression | 15958521 | GSE1792_DOC |
| Melanoma progression model:DAC-mediated gene expression | 15958521 | GSE1793_DOC |
| Human hematopoietic stem cell engraftment in goat | 16682618 | GSE1801_DOC |
| CBCD34-TGFbeta targets | 15477587 | GSE1802_DOC |
| TGFbeta targets in M091 cell line | 15477587 | GSE1805_DOC |
| The Influence of Interferon Gamma on Gene Expression in Normal Human Bronchial Epithelial Cells | 15985639 | GSE1815_DOC |
| EWS-FLI1-transfection of HEK293 | 15548687 | GSE1822_DOC |
| IL-2 transfection of A673-cells | 15170886 | GSE1823_DOC |
| Neuroblastoma cell lines | 15548687 | GSE1824_DOC |
| SRBCT | 15548687 | GSE1825_DOC |
| Time and Exercise effects on Human Skeletal Muscle | 14519196 | GSE1832_DOC |
| Melanoma cell lines | 15967107 | GSE1845_DOC |
| lung and tonsillar mast cells | 15470070 | GSE1848A_DOC |
| lung and tonsillar mast cells | 15470070 | GSE1848B_DOC |
| Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849A_DOC |
| Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849B_DOC |
| The search for enzymes responsible for metabolism of nucleoside analogs | | GSE1862_DOC |
| Ischemic and Nonischemic CM and NF Hearts | 15769906 | GSE1869_DOC |
| Role of LANA in KSHV latent infection | 15525642 | GSE1880_DOC |
| Sarcoidosis + Follow-up study | | GSE1907_DOC |
| Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. | 15579277 | GSE1910_DOC |
| Rheumatoid arthritis | | GSE1919_DOC |
| Leukemia study / K562 cell line | | GSE1922_DOC |
| Identification of PDGF-dependent patterns of gene expression in U87 glioblastoma cells | 15994924 | GSE1923_DOC |
| IFN-gamma priming | 16148108 | GSE1925_DOC |
| Carboplatin Sensitivity in Ovarian Carcinoma | 16227411 | GSE1926_DOC |
| Mast Cell_time series | 16911805 | GSE1933_DOC |
| Collagen-GAG Biocompatibility Tests | | GSE1937_DOC |
| Gene expression changes induced by K-ras oncogene in the human pancreatic duct epithelial cell line (H6c7) | | GSE1955_DOC |
| Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells | 15356296 | GSE1977_DOC |
| PBMCs from CCI-779 Treated RCC subjects | | GSE1982_DOC |
| Non Small Cell Lung Cancer | | GSE1987_DOC |
| scien-affy-human-87089 | | GSE2004_DOC |
| Comparative microarray between normal and essential thrombocythemia platelets | 16113833 | GSE2006_DOC |
| Human Lung Transplant - BAL | | GSE2018_DOC |
| Breast cancer relapse free survival | 15721472 | GSE2034_DOC |
| Human endothelial progenitor cells (EPC) vs. human umbilical vein endothelial cells (HUVEC) vs. CD14+ monocytes | 15665831 | GSE2040_DOC |
| Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044A_DOC |
| Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044B_DOC |
| AML1-ETO target genes | 15731354 | GSE2049_DOC |
| Characterize CREB target genes in different tissue types | 15753290 | GSE2060B_DOC |
| Characterize CREB target genes in different tissue types | 15753290 | GSE2060C_DOC |
| HCV_Core_Study | 16876223 | GSE2067_DOC |
| HDMTX_MP-1 pair | 12704389 | GSE207_DOC |
| Gene expression in Cryptosporidium parvum-infected human ileocecal adenocarcinoma cells (HCT-8) | 14711592 | GSE2077_DOC |
| HDMTX_MP-10 pair | 12704389 | GSE208_DOC |
| HDMTX_MP-2 pair | 12704389 | GSE209_DOC |
| control-ethanol liver RNA | 15705656 | GSE2099_DOC |
| HDMTX_MP-3 pair | 12704389 | GSE210_DOC |
| Expression Project for Oncology (expO) | | GSE2109_DOC |
| HDMTX_MP-4 pair | 12704389 | GSE211_DOC |
| Marrow-derived Mesenchymal stem cells(2004/12/24) | 15923633 | GSE2110_DOC |
| Metal and Gene Expression | 16330358 | GSE2111_DOC |
| Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma | 15735737 | GSE2113_DOC |
| CALM-AF10 T-ALL | 16107895 | GSE2117_DOC |
| HDMTX_MP-5 pair | 12704389 | GSE212_DOC |
| isolated alveolar macrophages | 16166618 | GSE2125_DOC |
| HDMTX_MP-6 pair | 12704389 | GSE213_DOC |
| Filaria induced monocyte dysfunction and its reversal following treatment | 16861626 | GSE2135_DOC |
| Colon cancer profiling | 16247484 | GSE2138A_DOC |
| Colon cancer profiling | 16247484 | GSE2138B_DOC |
| HDMTX_MP-7 pair | 12704389 | GSE214_DOC |
| Gene induction by low pH in oesophageal cells | 16113055 | GSE2144_DOC |
| Gene Expression Profile of Primary Effusion Lymphoma | | GSE2149_DOC |
| HDMTX_MP-8 pair | 12704389 | GSE215_DOC |
| The effect of FH mutations on fibroid expression profile | 16319128 | GSE2152_DOC |
| HDMTX_MP-9 pair | 12704389 | GSE216_DOC |
| Gender-specific gene expression in post-mortem human brain | 14583743 | GSE2164_DOC |
| HDMTX-1 pair | 12704389 | GSE217_DOC |
| HIV-1 infection in human PBMCs in vivo | 15897992 | GSE2171_DOC |
| D4-ME effects | | GSE2174_DOC |
| Differential gene expression in pituitary adenomas by oligonucleotide array analysis | 15994756 | GSE2175_DOC |
| HDMTX-10 pair | 12704389 | GSE218_DOC |
| A549 teatement with MGd | | GSE2189_DOC |
| HDMTX-11 pair | 12704389 | GSE219_DOC |
| pediatric AML and normal bone marrow | 12738660 | GSE2191_DOC |
| HDMTX-12 pair | 12704389 | GSE220_DOC |
| gene expression study of blood monocytes | 15965235 | GSE2208_DOC |
| HDMTX-13 pair | 12704389 | GSE221_DOC |
| HDMTX-14 pair | 12704389 | GSE222_DOC |
| FoxM1 siRNA profiles | 15958562 | GSE2222_DOC |
| Letrozole-, Anastrozole- and Tamoxifen-Responsive Genes in MCF-7aro Cells | 15831674 | GSE2225_DOC |
| HDMTX-15 pair | 12704389 | GSE223_DOC |
| Effects of hTERT overexpression on gene expression profiles in CD4+ T lymphocytes | 15741219 | GSE2230_DOC |
| Caco-2 cells cocultured with E.coli Nissle 1917 | 16351713 | GSE2232_DOC |
| Targets of cytostatic drugs in HT1080 fibrosarcoma | 16001973 | GSE2238_DOC |
| HDMTX-16 pair | 12704389 | GSE224_DOC |
| Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240A_DOC |
| Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240B_DOC |
| HOXA5 transcriptional targets | 15757903 | GSE2241_DOC |
| Human Mesenchymal stem cell | 15971941 | GSE2248_DOC |
| HDMTX-17 pair | 12704389 | GSE225_DOC |
| Anti-prolif. effect of E2 in breast cancer cells that re-exp. ERalpha is mediated by aberr. regulat. of cell cycle genes | 15821115 | GSE2251_DOC |
| Lens Epithelial Cells and Lens Cortical Fiber Cells | 15851978 | GSE2256_DOC |
| HDMTX-18 pair | 12704389 | GSE226_DOC |
| HDMTX-19 pair | 12704389 | GSE227_DOC |
| HDMTX-2 pair | 12704389 | GSE228_DOC |
| Prediction of lymphatic metastasis from primary squamous cell carcinoma of the oral cavity | 15558013 | GSE2280_DOC |
| HDMTX-20 pair | 12704389 | GSE229_DOC |
| U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 | 15802376 | GSE2292_DOC |
| A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors | 16740749 | GSE2294_DOC |
| hGSTA4-4 transfection in HLE B-3 experiment | 16005854 | GSE2298_DOC |
| Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299A_DOC |
| Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299B_DOC |
| HDMTX-21 pair | 12704389 | GSE230_DOC |
| HDMTX-22 pair | 12704389 | GSE231_DOC |
| HDMTX-3 pair | 12704389 | GSE232_DOC |
| Expression changes induced by transmigration in human neutrophils | 16861384 | GSE2322_DOC |
| Suqamous Cell Carcinoma of Head and Neck | | GSE2326A_DOC |
| Suqamous Cell Carcinoma of Head and Neck | | GSE2326B_DOC |
| siRNA mediated WTAP knockdown in HUVEC | | GSE2327_DOC |
| Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328A_DOC |
| Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328B_DOC |
| HDMTX-4 pair | 12704389 | GSE233_DOC |
| HDMTX-5 pair | 12704389 | GSE234_DOC |
| HDMTX-6 pair | 12704389 | GSE235_DOC |
| Normal and transformed human mature B cells | 15778709 | GSE2350_DOC |
| chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia | | GSE2351_DOC |
| HDMTX-7 pair | 12704389 | GSE236_DOC |
| HDMTX-8 pair | 12704389 | GSE237_DOC |
| HDMTX-9 pair | 12704389 | GSE238_DOC |
| LDMTX_MP-1 pair | 12704389 | GSE239_DOC |
| LDMTX_MP-10 pair | 12704389 | GSE240_DOC |
| LDMTX_MP-11 pair | 12704389 | GSE241_DOC |
| LDMTX_MP-12 pair | 12704389 | GSE242_DOC |
| Atypical Ductal Hyperplasia | 15864312 | GSE2429_DOC |
| LDMTX_MP-13 pair | 12704389 | GSE243_DOC |
| LDMTX_MP-14 pair | 12704389 | GSE244_DOC |
| Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor | 16203770 | GSE2443_DOC |
| LDMTX_MP-15 pair | 12704389 | GSE245_DOC |
| LDMTX_MP-16 pair | 12704389 | GSE246_DOC |
| LDMTX_MP-2 pair | 12704389 | GSE247_DOC |
| LDMTX_MP-3 pair | 12704389 | GSE248_DOC |
| LDMTX_MP-4 pair | 12704389 | GSE249_DOC |
| LDMTX_MP-5 pair | 12704389 | GSE250_DOC |
| LDMTX_MP-6 pair | 12704389 | GSE251_DOC |
| LDMTX_MP-7 pair | 12704389 | GSE252_DOC |
| LDMTX_MP-8 pair | 12704389 | GSE253_DOC |
| LDMTX_MP-9 pair | 12704389 | GSE254_DOC |
| MP-1 pair | 12704389 | GSE255_DOC |
| Mapping Determinants of Human Gene Expression by Regional and Whole Genome Association | 16251966 | GSE2552_DOC |
| MP-10 pair | 12704389 | GSE256_DOC |
| MP-11 pair | 12704389 | GSE257_DOC |
| MP-12 pair | 12704389 | GSE258_DOC |
| MP-2 pair | 12704389 | GSE259_DOC |
| MP-3 pair | 12704389 | GSE260_DOC |
| Subpopulations of MDA-MB-231 and Primary Breast Cancers | 16049480 | GSE2603_DOC |
| MP-4 pair | 12704389 | GSE261_DOC |
| MP-5 pair | 12704389 | GSE262_DOC |
| MP-6 pair | 12704389 | GSE263_DOC |
| MP-7 pair | 12704389 | GSE264_DOC |
| MP-8 pair | 12704389 | GSE265_DOC |
| MP-9 pair | 12704389 | GSE266_DOC |
| LDMTX_MP | 12704389 | GSE267_DOC |
| HDMTX | 12704389 | GSE268_DOC |
| HDMTX_MP | 12704389 | GSE269_DOC |
| MP | 12704389 | GSE270_DOC |
| The effect of FH mutations on fibroid expression profile, normal myometrium vs. FH-mutant fibroids. | 16319128 | GSE2724_DOC |
| Inflammatory myopathy | 12391344 | GSE281_DOC |
| Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | 16478745 | GSE2990_DOC |
| Actions of tamoxifen in the uterus and its molecular effectors in endometrial carcinogenesis. | 16355216 | GSE3013_DOC |
| Lung Cancer Dataset | 16273092 | GSE3141_DOC |
| Breast Cancer Dataset | 16273092 | GSE3143_DOC |
| Breast Cancer Cell Lines | 16273092 | GSE3156_DOC |
| Human Glioblastoma | | GSE3185A_DOC |
| Human Glioblastoma | | GSE3185B_DOC |
| Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188A_DOC |
| Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188B_DOC |
| Resistant | 12907009 | GSE349_DOC |
| An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494A_DOC |
| An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494B_DOC |
| Sensitive | 12907009 | GSE350_DOC |
| Profiling of three different ER+ breast cancer cell lines grown in the presence and absence of estrogen. | 15986123 | GSE3529_DOC |
| Profiling of MCF-7 cell lines stably overexpressing (ca)Raf-1, (ca)MEK, (ca)erbB-2, or ligand-activatable EGFR. | 16585219 | GSE3542_DOC |
| Leukotriene D4- and Thrombin-Triggered Transcriptomes in Human Umbilical Vein Endothelial Cells | 16606835 | GSE3589_DOC |
| Macrophages and dendritic cells exposed to phylogenetically distinct parasites | 12663451 | GSE360_DOC |
| Human breast tumor expression | 16473279 | GSE3744_DOC |
| Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | | GSE3834A_DOC |
| Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | | GSE3834B_DOC |
| Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893A_DOC |
| Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893B_DOC |
| Heterozygous carriers of Nijmegen Breakage Syndrome Have a Distinct Gene Expression Phenotype. | 16809669 | GSE3894_DOC |
| Estrogen effects on MCF-7 breast cancer cells co-expressing ERa and ERb | 16809442 | GSE4006_DOC |
| Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells | 16849584 | GSE4025_DOC |
| Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 12704389 | GSE412_DOC |
| Aortic stiffness | 14530203 | GSE420_DOC |
| Human Fibroblast Set: Hacia Laboratory | 12840040 | GSE427_DOC |
| PTHrP-responsive genes in breast cancer | 16551631 | GSE4292_DOC |
| Effect of left ventricular assist device support on congestive heart failure patients | 12824457 | GSE430_DOC |
| Leprosy lesion gene expression | 12970564 | GSE443_DOC |
| WS1 response to high dose of UV-C | 12907719 | GSE448_DOC |
| WS1 response to low dose of UV-C | 12907719 | GSE449_DOC |
| Gene expression signatures for predicting prognosis of squamous cell lung carcinomas | 16885343 | GSE4573_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465A_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465B_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465C_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465D_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465E_DOC |
| Expression data from hormone-starved MCF7/BUS cell culture | 14610279 | GSE4668_DOC |
| Expression profiling of medulloblastoma | 11544480 | GSE468_DOC |
| Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | | GSE4922A_DOC |
| Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | | GSE4922B_DOC |
| Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493A_DOC |
| CD34+ cell analysis | 11669215 | GSE500_DOC |
| Genomic profile of the estrogen induced neoplastic transformation of the human breast epithelial cell MCF10F | | GSE5102_DOC |
| Proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF | 11839152 | GSE511_DOC |
| TNF treated Synoviocytes | 12965196 | GSE516_DOC |
| Breast cancer relapse free survival and lung metastasis free survival | 17420468 | GSE5327_DOC |
| Essential Thrombocythemia (ET) vs Normal (baseline) Megakaryocytes | 15271793 | GSE567_DOC |
| Idiopathic thrombocytopenic purpura (ITP) | 12937414 | GSE574_DOC |
| Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859A_DOC |
| USF1 haplotype comparison | 14991056 | GSE590_DOC |
| Human skeletal muscle | 14625377 | GSE595_DOC |
| SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609A_DOC |
| SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609B_DOC |
| Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620A_DOC |
| Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620B_DOC |
| A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253A_DOC |
| A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253B_DOC |
| A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253C_DOC |
| Identification of novel genomic determinants of cellular drug resistance in acute lymphoblastic leukemia. | 15295046 | GSE635_DOC |
| HGPC, in monolayer, 0.5 vs. 20% serum, complete | | GSE6429_DOC |
| ASP sensitive all ALL | 15295046 | GSE643_DOC |
| Docetaxel treatment of sensitve and resistant patients | | GSE6434_DOC |
| ASP resistant all ALL | 15295046 | GSE645_DOC |
| PRED sensitive all ALL | 15295046 | GSE646_DOC |
| PRED resistant all ALL | 15295046 | GSE647_DOC |
| VCR sensitive all ALL | 15295046 | GSE648_DOC |
| VCR resistant all ALL | 15295046 | GSE649_DOC |
| Insulin sensitive muscle sample pool 1 | 12436343 | GSE64A_DOC |
| Insulin sensitive muscle sample pool 1 | 12436343 | GSE64B_DOC |
| Insulin sensitive muscle sample pool 1 | 12436343 | GSE64C_DOC |
| Insulin sensitive muscle sample pool 1 | 12436343 | GSE64D_DOC |
| Insulin sensitive muscle sample pool 1 | 12436343 | GSE64E_DOC |
| DNR sensitive all ALL | 15295046 | GSE650_DOC |
| DNR resistant all ALL | 15295046 | GSE651_DOC |
| ASP sensitive B-ALL | 15295046 | GSE653_DOC |
| Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532A_DOC |
| Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532B_DOC |
| Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532C_DOC |
| ASP resistant B-ALL | 15295046 | GSE654_DOC |
| PRED sensitive B-ALL | 15295046 | GSE655_DOC |
| PRED resistant B-ALL | 15295046 | GSE656_DOC |
| VCR sensitive B-ALL | 15295046 | GSE657_DOC |
| VCR resistant B-ALL | 15295046 | GSE658_DOC |
| DNR sensitive B-ALL | 15295046 | GSE659_DOC |
| Insulin sensitive muscle sample pool 2 | 12436343 | GSE65A_DOC |
| Insulin sensitive muscle sample pool 2 | 12436343 | GSE65B_DOC |
| Insulin sensitive muscle sample pool 2 | 12436343 | GSE65C_DOC |
| Insulin sensitive muscle sample pool 2 | 12436343 | GSE65D_DOC |
| Insulin sensitive muscle sample pool 2 | 12436343 | GSE65E_DOC |
| DNR resistant B-ALL | 15295046 | GSE660_DOC |
| Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604A_DOC |
| Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604B_DOC |
| Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604C_DOC |
| Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605A_DOC |
| Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605B_DOC |
| Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605C_DOC |
| Expression data from Primary Prostate Tumor | 17430594 | GSE6606A_DOC |
| Expression data from Primary Prostate Tumor | 17430594 | GSE6606B_DOC |
| Expression data from Primary Prostate Tumor | 17430594 | GSE6606C_DOC |
| Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608A_DOC |
| Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608B_DOC |
| Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608C_DOC |
| Insulin sensitive muscle sample pool 3 | 12436343 | GSE66A_DOC |
| Insulin sensitive muscle sample pool 3 | 12436343 | GSE66B_DOC |
| Insulin sensitive muscle sample pool 3 | 12436343 | GSE66C_DOC |
| Insulin sensitive muscle sample pool 3 | 12436343 | GSE66D_DOC |
| Insulin sensitive muscle sample pool 3 | 12436343 | GSE66E_DOC |
| Time course analysis of response to HCMV infection | 11711622 | GSE675_DOC |
| Insulin sensitive muscle sample pool 4 | 12436343 | GSE67A_DOC |
| Insulin sensitive muscle sample pool 4 | 12436343 | GSE67B_DOC |
| Insulin sensitive muscle sample pool 4 | 12436343 | GSE67C_DOC |
| Insulin sensitive muscle sample pool 4 | 12436343 | GSE67D_DOC |
| Insulin sensitive muscle sample pool 4 | 12436343 | GSE67E_DOC |
| DACH1 inhibits TGF-beta signaling through binding Smad4 | 14525983 | GSE685_DOC |
| Insulin sensitive muscle sample pool 5 | 12436343 | GSE68A_DOC |
| Insulin sensitive muscle sample pool 5 | 12436343 | GSE68B_DOC |
| Insulin sensitive muscle sample pool 5 | 12436343 | GSE68C_DOC |
| Insulin sensitive muscle sample pool 5 | 12436343 | GSE68D_DOC |
| Insulin sensitive muscle sample pool 5 | 12436343 | GSE68E_DOC |
| Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919A_DOC |
| Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919B_DOC |
| Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919C_DOC |
| Insulin resistant muscle sample pool 1 | 12436343 | GSE69A_DOC |
| Insulin resistant muscle sample pool 1 | 12436343 | GSE69B_DOC |
| Insulin resistant muscle sample pool 1 | 12436343 | GSE69C_DOC |
| Insulin resistant muscle sample pool 1 | 12436343 | GSE69D_DOC |
| Insulin resistant muscle sample pool 1 | 12436343 | GSE69E_DOC |
| Transcriptional response of lymphoblastoid cells to ionizing radiation | 12915489 | GSE701_DOC |
| Blood pulmonary arterial hypertension | 15215156 | GSE703_DOC |
| Insulin resistant muscle sample pool 2 | 12436343 | GSE70A_DOC |
| Insulin resistant muscle sample pool 2 | 12436343 | GSE70B_DOC |
| Insulin resistant muscle sample pool 2 | 12436343 | GSE70C_DOC |
| Insulin resistant muscle sample pool 2 | 12436343 | GSE70D_DOC |
| Insulin resistant muscle sample pool 2 | 12436343 | GSE70E_DOC |
| UV radiation-induced DNA damage | 12907719 | GSE713_DOC |
| Insulin resistant muscle sample pool 3 | 12436343 | GSE71A_DOC |
| Insulin resistant muscle sample pool 3 | 12436343 | GSE71B_DOC |
| Insulin resistant muscle sample pool 3 | 12436343 | GSE71C_DOC |
| Insulin resistant muscle sample pool 3 | 12436343 | GSE71D_DOC |
| Insulin resistant muscle sample pool 3 | 12436343 | GSE71E_DOC |
| Insulin resistant muscle sample pool 4 | 12436343 | GSE72A_DOC |
| Insulin resistant muscle sample pool 4 | 12436343 | GSE72B_DOC |
| Insulin resistant muscle sample pool 4 | 12436343 | GSE72C_DOC |
| Insulin resistant muscle sample pool 4 | 12436343 | GSE72D_DOC |
| Insulin resistant muscle sample pool 4 | 12436343 | GSE72E_DOC |
| Human body index - transcriptional profiling | | GSE7307_DOC |
| Strong Time Dependence of the 76-Gene Prognostic Signature | 17545524 | GSE7390_DOC |
| Insulin resistant muscle sample pool 5 | 12436343 | GSE73A_DOC |
| Insulin resistant muscle sample pool 5 | 12436343 | GSE73B_DOC |
| Insulin resistant muscle sample pool 5 | 12436343 | GSE73C_DOC |
| Insulin resistant muscle sample pool 5 | 12436343 | GSE73D_DOC |
| Insulin resistant muscle sample pool 5 | 12436343 | GSE73E_DOC |
| MRI-no-lytic-lesion | 14695408 | GSE753_DOC |
| MRI-lytic-lesion | 14695408 | GSE754_DOC |
| MRI lytic and no lytic lesions | 14695408 | GSE755_DOC |
| Gene expression in human optic nerve head (ONH) astrocytes | 14747662 | GSE758_DOC |
| Comparison of Gene Expression in Uterine Smooth Muscle Tumors | | GSE764_DOC |
| Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781A_DOC |
| Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781B_DOC |
| GeneNote-Gene Normal tissue Expression | 15388519 | GSE803A_DOC |
| GeneNote-Gene Normal tissue Expression | 15388519 | GSE803B_DOC |
| GeneNote-Gene Normal tissue Expression | 15388519 | GSE803C_DOC |
| GeneNote-Gene Normal tissue Expression | 15388519 | GSE803D_DOC |
| GeneNote-Gene Normal tissue Expression | 15388519 | GSE803E_DOC |
| Gene expression data from prostate cancer samples | | GSE8218_DOC |
| Conversion | 14702632 | GSE846_DOC |
| HS to HR progression | 14702632 | GSE847_DOC |
| E2 and SERM Treatment of MCF-7 Breast Cancer Cells | 14973112 | GSE848_DOC |
| Bladder tumour recurrence prediction | 12469123 | GSE88_DOC |
| Bladder tumour stage classification | 12469123 | GSE89_DOC |
| Pseudomonas aeruginosa infection of Calu-3 human lung epithelial cells | 15494517 | GSE923_DOC |
| NIH/NIAID Chronic Granulomatous Disease Neutrophils | 14688376 | GSE935_DOC |
| Large-scale analysis of the human transcriptome | 11904358 | GSE96_DOC |
| IL-1 stimulation of HUVEC | 15130917 | GSE973_DOC |
| Left ventricular apex samples | 14872006 | GSE974_DOC |
| Gene Expression-Based High Throughput Screening: APL Treatment with Candidate Compounds | 14770183 | GSE976_DOC |
| Endothelin-1 (ET-1) treated lung fibroblasts | | GSE981_DOC |
| Gene Expression-Based High Throughput Screening: HL-60 Cell Treatment with Candidate Compounds | 14770183 | GSE982_DOC |
| Gene Expression-Based High Throughput Screening: Primary Patient AML Blasts, Normal Neutrophils, and Normal Monocytes | 14770183 | GSE983_DOC |
| Gene Expression-Based High Throughput Screening: HL-60 Cells Treated with ATRA and PMA | 14770183 | GSE985_DOC |
| Differentiation of acute myeloid leukemia cells | 14770183 | GSE995A_DOC |
| Differentiation of acute myeloid leukemia cells | 14770183 | GSE995B_DOC |
| Essential Thrombocythemia megakaryocytes versus normal megakaryocytes | 15271793 | GSE997_DOC |
| Amino Acid Conjugated Surfaces and Controls 6 Hours | | GSE998_DOC |
| Amino Acid Conjugated Surfaces and Controls 32 Hours | | GSE999_DOC |
BASIC 33 | | Classification of human astrocytic gliomas | 14583454 | C0001_DOC |
| Concurrent Versus Individual Binding of HuR and AUF1 to Common Labile Target mRNAs | 15257295 | GSE1361_DOC |
| Natural variation in human gene expression assessed in lymphoblastoid cells | 12567189 | GSE137_DOC |
| TIAR represses c-Myc biosynthesis following ultraviolet light irradiation | 16537914 | GSE1433_DOC |
| HaCaT +GLI1/2 24/72h | 16434164 | GSE1434_DOC |
| TIAR represses c-Myc biosynthesis following ultraviolet light irradiation-2 | | GSE1440_DOC |
| Human UniGene Set RZPD 1 - Zipf's Normalization | | GSE1510_DOC |
| Gene expression profile of CD56dimCD16+, CD56brightCD16- and activated CD56+CD16+ human NK subsets | 15557145 | GSE1511_DOC |
| Expression profiling in inflammatory bowel disease | 16107186 | GSE1710_DOC |
| VI-28 treatment induced alteration of gene expression in human lymphocytes | | GSE1748_DOC |
| Human blood expression for Huntington's disease versus control, Codelink | 16043692 | GSE1767_DOC |
| Comparison of native versus cultured RPE cells | 16234463 | GSE1836_DOC |
| Hep3B time-course | | GSE2046_DOC |
| IPF versus Control | 16128620 | GSE2052_DOC |
| RAvs.ND | | GSE2053_DOC |
| Rosetta_miRNA_transfection_experiment | 15685193 | GSE2075_DOC |
| Epigenetic treatment of cervical carcinoma cell lines | 16434596 | GSE2097_DOC |
| Human coronary artery study | 15942018 | GSE2143_DOC |
| Trascriptional profiling of angiogenic inhibitors | 12499246 | GSE2177_DOC |
| Drug treatment comparison | | GSE2182_DOC |
| RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia... | 16953217 | GSE2243_DOC |
| Human breast tumor | | GSE2845_DOC |
| Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155A_DOC |
| Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155B_DOC |
| Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | | GSE3155C_DOC |
| cDNA array of the new human breast cancer cell line EM-G3 derived from breast cancer progenitor cells | | GSE3570_DOC |
| Expression profiling of human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel | 16622258 | GSE4056_DOC |
| Expression profiling in the muscular dystrophies | 11121445 | GSE465F_DOC |
| Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716A_DOC |
| Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716B_DOC |
| A Gene Expression Signature to Predict Metastasis and Survival in Non-small Cell Lung Cancer | 17202451 | GSE4882_DOC |
| Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493B_DOC |
| CodeLink Expression Data from primary prostate tumor and prostate tumor metastases | 17430594 | GSE6752_DOC |
COUNTS 23 | | eye-SAGE | 11756676 | GSE10_DOC |
| CGAP SAGE | 11257097 | GSE14_DOC |
| Differentiation of cultured THP-1 cells | | GSE1439_DOC |
| Young and old muscle comparison | 10904065 | GSE17_DOC |
| Human 32 MPSS samples | | GSE1747_DOC |
| Cancer Genome Anatomy Project (Human: longSAGE) | | GSE1902_DOC |
| Genomic alterations in primary hyperaldosteronism | 16204365 | GSE2017_DOC |
| Human Adrenal Cortex affected by Primary Pigmented Nodular Adrenocortical Disease | | GSE2055_DOC |
| PBECs stimulated with pro-inflammatory cytokines and P. aeruginosa | 15701729 | GSE2056_DOC |
| The pattern of gene expression in human CD34(+) stem/progenitor cells | 11717454 | GSE2346_DOC |
| Pancreas and islet gene expression | | GSE278_DOC |
| SAGE_HumanEpidermis | 11772949 | GSE31_DOC |
| Effects of estrogen | 11085516 | GSE41_DOC |
| Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy | 12556388 | GSE505_DOC |
| Fibroblast cells immediate-early after human cytomegalovirus infection | 11124023 | GSE506_DOC |
| Novel estrogen and tamoxifen induced genes | 11850811 | GSE507_DOC |
| Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation | 12036942 | GSE508_DOC |
| AIDS-related Kaposi's sarcoma | 12697073 | GSE514_DOC |
| SAGE Hiroshima gastric cancer tissue | 15059891 | GSE545_DOC |
| Human embryonic stem cells | 14688391 | GSE608_DOC |
| SADE analysis of microdissected kidney | 14595018 | GSE694_DOC |
| Effect of TERT and ATM on Gene Expression Profiles in Human Fibroblasts | 14978791 | GSE953_DOC |
| Tissue break-down of ESTs derived from Unigene clusters | 8849440 | HSEST_DOC |
CUSTOM
| | tissue-specific pattern of mRNA expression | 15075390 | GSE1133B_DOC |
DUAL 105 | | NHGRI_Melanoma_class | 10952317 | GSE1_DOC |
| H295RAII3h | 15375197 | GSE1030A_DOC |
| H295RAII3h | 15375197 | GSE1030B_DOC |
| Lung cancer | | GSE1037_DOC |
| Differential Gene Expression by Memory T Helper Cells Bearing the Gut-Homing Receptor Integrin beta 7+ and beta 7- | 15236665 | GSE1039_DOC |
| Responses of HUVEC to Hypoxia and Reoxygenation | | GSE1041_DOC |
| Lipopolysaccharide-stimulated neutrophils | 12495940 | GSE105_DOC |
| EP300 knock-out image segmentation | 15028803 | GSE1054_DOC |
| Human lupus and normal CD4 T cells response to anti-CD3 treatment | | GSE1057_DOC |
| Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | | GSE112A_DOC |
| Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | | GSE112B_DOC |
| Effect of cigarette smoke on normal human bronchial epithelial cells, and S9 toxicity | 15326394 | GSE1276_DOC |
| Tubular carcinoma and adenoma | 15800983 | GSE1279_DOC |
| Cytokine Stimulated Vs Unstimulated | | GSE1288_DOC |
| Adenovirus vs Mock Infection | | GSE1291_DOC |
| HSP27 3A vs WT | | GSE1292_DOC |
| Immunohistochemical and Clinical Characterization of the Basal-like Subtype | 15328174 | GSE1319_DOC |
| Total-body irradiation dose response | 15374940 | GSE1366_DOC |
| Sham-irradiated vs pool of sham-irradiated keratinocytes | 15691830 | GSE1369_DOC |
| Irradiated vs sham irradiated keratynocytes | 15691830 | GSE1370_DOC |
| breast cancer / tamoxifen monotherapy (microdissected tumor biopsies) | 15193263 | GSE1378_DOC |
| breast cancer / tamoxifen monotherapy (whole tissue tumor biopsies) | 15193263 | GSE1379_DOC |
| vGPCR and lytic KSHV time course in TIME cells | 15289507 | GSE1406_DOC |
| PDGF stimulation kinetics | 15213220 | GSE1484_DOC |
| Steroids_Effect_on_HUVEC_Response_to_LPS_or_Cytokines | | GSE1486_DOC |
| DU 145 EMETINE TIME COURSE | 15300251 | GSE1487_DOC |
| LNCaP EMETINE TIME COURSE | 15300251 | GSE1488_DOC |
| PC3 EMETINE TIME COURSE | 15300251 | GSE1489_DOC |
| GM00156 EMETINE TIME COURSE | 15300251 | GSE1490_DOC |
| Human podocyte differentiation | | GSE1545_DOC |
| Intestinal cells infected with Vibrio cholerae | 15213169 | GSE1549_DOC |
| TAcKLE - Transcriptome Amplification and cDNA Labeling for Expression analysis | 15718295 | GSE1645_DOC |
| Prediction of toxicant-specific gene expression signatures following chemotherapeutic treatment of breast cell lines | 15598611 | GSE1647_DOC |
| Promyelocytic cells response to Anaplasma phagocytophilum infection | 15760455 | GSE1694_DOC |
| Epithelial cells in contact with bacterial supernatant | 15598879 | GSE1704_DOC |
| EGFR inhibitors block basal-like breast cancer growth | | GSE1705_DOC |
| mCGH of cervical cancer | | GSE1715_DOC |
| Pre- and Post-training arrays/Insulin sensitivity response | 15687108 | GSE1718_DOC |
| Rosetta_Merck_CEPH_Study | 15514893 | GSE1726_DOC |
| Array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas | 15163005 | GSE1755_DOC |
| Testicular germ cell tumors and their histological subgroups | 15994931 | GSE1818_DOC |
| Waldman Bladder tumors | | GSE1827_DOC |
| A genomic view of estrogen actions in human breast cancer cells | 15171711 | GSE1864_DOC |
| Human Hepatocellular Carcinoma study | 15565109 | GSE1898_DOC |
| Immortalization of normal human cells | 15942647 | GSE1900_DOC |
| Array-CGH in human glial brain tumors | 15899798 | GSE1991_DOC |
| A New Breast Tumor Intrinsic Gene List Identifies Novel Characteristics that are Conserved Across Microarray Platforms | 16643655 | GSE1992_DOC |
| NCI cDNA microarray-human 60 cell lines | 10700174 | GSE2003_DOC |
| Molecular classification of failing hearts from coronary and myopathic patients | | GSE2014_DOC |
| Differential Gene Up-regulation by HIF-1a and HIF-2a in HEK293T. | 15833863 | GSE2020_DOC |
| Hearts_DD_Screening | | GSE2035_DOC |
| folic acid | | GSE2047_DOC |
| Breast Cancer: Invasive Ductal Carcinoma | | GSE2048_DOC |
| Hearts_tissue_expression_profile | | GSE2051_DOC |
| Identification of drug associated genes in ovarian cancer by RNA profiling | | GSE2058_DOC |
| Hearts_tissue_expression_profile_2 | | GSE2061_DOC |
| Hearts_tissue_expression_profile_3 | | GSE2062_DOC |
| Microarray Analysis of Gene Expression in Human Normal and Breast Cancer Cells | 15659406 | GSE2155_DOC |
| Expression profiling of secreted and cell surface genes of 5 transformed cell lines and derivative xenograft tumors | | GSE2179_DOC |
| Normal_human_tissues | 15774023 | GSE2193_DOC |
| Normal_human_tissues_genomic_controls | | GSE2194_DOC |
| Drug resistance in glioblastoma | 16365179 | GSE2221_DOC |
| Gene expression profiling in human glial brain tumors | 16204036 | GSE2223_DOC |
| Primary human neuroblastoma | 15837623 | GSE2283A_DOC |
| Primary human neuroblastoma | 15837623 | GSE2283B_DOC |
| Human TK6 cells treated with BPDE or N-OH-AABP yielding 5%, 15% and 40% of toxicity | | GSE2345_DOC |
| Gene expression patterns induced by 5-Fluorouracil in breast cancer cell lines | 16557594 | GSE2584_DOC |
| Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology | 16626501 | GSE2607_DOC |
| Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers | 16505416 | GSE2740_DOC |
| Breast Tumor's study | 16230372 | GSE2741_DOC |
| RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer | 11533059 | GSE2987_DOC |
| Identification of conserved gene expression features across human and murine mammary tumors murine mammary tumors | | GSE3165A_DOC |
| Gene expression patterns associated with p53 status in breast cancer | 17150101 | GSE3178_DOC |
| Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles of bladder cancer | | GSE3192_DOC |
| Breast Tumor Clinical Implications | 11553815 | GSE3193_DOC |
| Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia | 11733578 | GSE3211_DOC |
| Breast Cancer aCGH | 12297621 | GSE3281_DOC |
| Analysis of breast tumors and metastases identify a molecular signature of the Warburg effect and fibroblast patterns | | GSE3521_DOC |
| Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | | GSE3762A_DOC |
| Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | | GSE3762B_DOC |
| Response of quiescent human fibroblasts to different growth factors and serum | | GSE3901_DOC |
| Prostate Cancer | 14711987 | GSE3933_DOC |
| Prostate cancer cell line LNCaP treated for 2, 4, 6, 8 h with the synthetic androgen R1881 (1nM) | 16707422 | GSE4027_DOC |
| Acute myeloid leukemia study | 15084693 | GSE425_DOC |
| Breast and ovarian carcinoma | 12960427 | GSE4268_DOC |
| Norway/Stanford Breast Tumors | 12829800 | GSE4335_DOC |
| Repeated observation of breast tumor subtypes in independent gene expression data sets | 12829800 | GSE4382_DOC |
| Human mammary epithelium and breast cancer | 10430922 | GSE53_DOC |
| Serum stimulation of fibroblasts experiment set | 9872747 | GSE55_DOC |
| Serum stimulation of fibroblasts with cycloheximide | 9872747 | GSE56_DOC |
| Serum stimulation of fibroblasts controls | 9872747 | GSE57_DOC |
| Serum stimulation of fibroblasts | 9872747 | GSE58_DOC |
| gene differentially expressed in androgen independent prostate cancer | | GSE5803_DOC |
| Gene expression profiling classifies lung squamous cell carcinomas with N1 positive lymph nodes | 17601969 | GSE5828_DOC |
| Expression profiling defines a recurrence signature in lung adenocarcinoma | 17082175 | GSE5843_DOC |
| Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859B_DOC |
| Diffuse large B-cell lymphoma | 10676951 | GSE60_DOC |
| Molecular portraits of human breast tumors | 10963602 | GSE61_DOC |
| EGFR signaling varies with breast tumor subtype | 17663798 | GSE6128_DOC |
| Agreement in Breast Cancer Classification between Microarray and qRT-PCR from Fresh-Frozen and Formalin-Fixed Tissues | | GSE6130_DOC |
| Role of E2F3 expression in human bladder and prostate cancer cells | 16909110 | GSE6131_DOC |
| Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues | 17044071 | GSE6250_DOC |
| Cell-type specific responses to chemotherapeutics in breast cancer | 15205334 | GSE763_DOC |
| Comparison and classification of breast cancers | 11823860 | R0001_DOC |
| Survival in breast cancer. | 12490681 | R0002_DOC |
Mouse 326 | AFFY 180 | | Extraocular muscle, comparison of wild type and mdx mice, 14 to 112 Days (Porter lab) | 12874102 | GSE1008_DOC |
| Chronic Rosiglitazone Mouse Aorta | 15054141 | GSE1011_DOC |
| Leg muscle mdx and control | | GSE1018_DOC |
| Hindlimb muscle, comparison of wild type and mdx mice, 7 to 112 Day (Porter lab) | 12874102 | GSE1025_DOC |
| Diaphram, comparison of wild type and mdx mice, 7 to 112 Days (Porter lab) | 14681298 | GSE1026_DOC |
| Cell Culture A and B chips EOM | 16291736 | GSE1049A_DOC |
| Cell Culture A and B chips EOM | 16291736 | GSE1049B_DOC |
| Difference in skeletal muscle function in Males vs Females; Role of Estrogen Receptor Beta | 15280152 | GSE1050_DOC |
| Cell Culture A and B chips leg | 16291736 | GSE1052A_DOC |
| Cell Culture A and B chips leg | 16291736 | GSE1052B_DOC |
| OVX/P4/UTX 129/SvImJ WT A | 12554760 | GSE106_DOC |
| Extraocular, masticatory, and hindlimb muscles, comparison of putative muscle allotypes (Porter lab) | 11572940 | GSE1062_DOC |
| OVX/P4/UTX 129/SvImJ WT B | 12554760 | GSE107_DOC |
| OVX/P4/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE108_DOC |
| Profiling of aggressive vs benign pancreatic infiltrates in the BDC2.5 Tg model of Type I diabetes | 15141080 | GSE1085_DOC |
| Dwarf Ad libitum | | GSE1086_DOC |
| Dwarf Calorie Restricted | 15039484 | GSE1087_DOC |
| Normal Ad Libitum | 15039484 | GSE1088_DOC |
| Normal Calorie Restricted | 15039484 | GSE1089_DOC |
| OVX/oil/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE109_DOC |
| SJL, Balb: Leg and Eye, 10/12 months | | GSE1092_DOC |
| caloric restriction | 15039484 | GSE1093_DOC |
| Hair follicle stem cell gene profile | 15024388 | GSE1096_DOC |
| Antisense IL-10 treatment in Malignant Murine B-1 Cells | | GSE1108_DOC |
| RTOC thymocytes | 15133507 | GSE1112_DOC |
| C3H10T1/2 Adipogenesis: Effects of EGF and TCDD | | GSE1123_DOC |
| Osteoblast differentiation experiment: BMP-2 induced osteogenesis in mouse MC3T3 cell line | 15178686 | GSE1131_DOC |
| Na,K-ATPase alpha 1 het. heart | | GSE1134_DOC |
| Insulin-like growth factor 1 (IGF1) heart study | 14597618 | GSE1143_DOC |
| Sex Specific Transciption in Mouse Tissues | | GSE1148_DOC |
| P7 wildtype | | GSE117_DOC |
| P10 wildtype | | GSE118_DOC |
| P14 wildtype | | GSE119_DOC |
| P18 wildtype | | GSE120_DOC |
| P21 wildtype | | GSE122_DOC |
| P7 knockout | | GSE123_DOC |
| P10 knockout | | GSE124_DOC |
| P14 knockout | | GSE125_DOC |
| P18 knockout | | GSE126_DOC |
| P21 knockout | | GSE127_DOC |
| Rp1 knockout mice retinal development | 16126734 | GSE128_DOC |
| Expression profile of genes in normal and Down syndrome mouse brains MGU74A | 15138197 | GSE1281_DOC |
| Expression profile of genes in normal and Down syndrome mouse brains MGU74B | 15138197 | GSE1282_DOC |
| KPAW and wild type eyes | | GSE1283_DOC |
| Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294A_DOC |
| Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294B_DOC |
| PGA Murine IL-13 Asthma | | GSE1301A_DOC |
| PGA Murine IL-13 Asthma | | GSE1301B_DOC |
| PGA Murine Lung Estrogen | | GSE1303_DOC |
| Effects of ethanol on poly IC gene induction | 15294990 | GSE1308_DOC |
| Hypoxic response in wild type and HIF-1alpha null hepatoctyes | | GSE1321_DOC |
| Erythroid Progenitor Cell Gene Expression Profiles | | GSE135_DOC |
| Embryonic Testis Developmental Time Course | 15496517 | GSE1358A_DOC |
| Embryonic Testis Developmental Time Course | 15496517 | GSE1358B_DOC |
| Embryonic Testis Developmental Time Course | 15496517 | GSE1358C_DOC |
| Embryonic Ovary Developmental Time Course | 15496517 | GSE1359A_DOC |
| Embryonic Ovary Developmental Time Course | 15496517 | GSE1359B_DOC |
| Embryonic Ovary Developmental Time Course | 15496517 | GSE1359C_DOC |
| Gene expression in T1alpha null mutant lungs compared to wild type at dpc 18.5 and term | | GSE1363_DOC |
| PS cDKO / Control, 6 months | 15345711 | GSE1375_DOC |
| Snell Dwarf Response to 3-NPA | | GSE1381_DOC |
| IL10-/-DC + 0,SEA,LPS,SEA/LPS 6H | 15585871 | GSE1382_DOC |
| Preimplantation mouse embryo development U74Av2 | 15282163 | GSE1391_DOC |
| Comparison of conventional and germ-free gastrointestinal tract | 15226484 | GSE1392_DOC |
| Zfp145 spermatogonia | 15156143 | GSE1399A_DOC |
| Zfp145 spermatogonia | 15156143 | GSE1399B_DOC |
| Zfp145 spermatogonia | 15156143 | GSE1399C_DOC |
| Murine bone marrow B cell precursors | 11779835 | GSE13A_DOC |
| Murine bone marrow B cell precursors | 11779835 | GSE13B_DOC |
| Pancreatic T regulatory vs. T effector cells | 15184501 | GSE1419_DOC |
| Global analysis of genes differentially expressed in branching and non-branching regions of the mouse embryonic lung | 15328023 | GSE1423_DOC |
| Microarray Based Comparison of two Amplification Methods For Nanogram Amounts of Total RNA | 15613496 | GSE1435_DOC |
| F9 cells after exposure to RA or TSA | 15467438 | GSE1437_DOC |
| Engagement of TCR with antibodies | 15661827 | GSE1448_DOC |
| CxVB3 infection and cardiac function | | GSE1457_DOC |
| Pioglitazone, rosiglitazone and troglitazone treatment | 15217816 | GSE1458_DOC |
| LPS effects on macrophages | 15640147 | GSE1459_DOC |
| Extraocular, hindlimb, and cardiac muscles, comparison of dko and mdx mice (Porter lab) | 16525850 | GSE1463_DOC |
| Hepatic reductase null | | GSE1468_DOC |
| Cardiac muscle, comparisons of wild type and mdx mice, 8 week and 10.5 month (Porter lab) | | GSE1471_DOC |
| Extraocular and hindlimb muscle, comparison of wild type and mdx mice, 56 days (Porter lab) | 11823445 | GSE1472_DOC |
| C57BL/6 Benchmark Set for Early Cardiac Development | | GSE1479_DOC |
| Murine Neurofibromatosis | | GSE1482_DOC |
| gene activation by IFNs in wild type and Pias1 null BMMs | 15311277 | GSE1552_DOC |
| Vehicle and sAPPalpha-treated hippocampal slice cultures | 15342738 | GSE1555_DOC |
| Control vs. APPSw mice gene expressions | | GSE1556_DOC |
| HSC 5-FU time course | 15459755 | GSE1559_DOC |
| Ezh2 deficiency in double negative thymocytes | | GSE1565_DOC |
| Ezh2 deficient T-cell | | GSE1566_DOC |
| Keratinocytes in embryos and newborns, and Notch1 expression in newborns | 15068794 | GSE1569_DOC |
| Muscle and Bone marrow SP and MP cells | | GSE1571_DOC |
| Subconfluent and confluent aortic endothelial cells | | GSE1576_DOC |
| Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578A_DOC |
| Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578B_DOC |
| Conditional activation of B-catenin in adult mouse epidermis for 0, 1, or 7 days | 15992546 | GSE1579_DOC |
| EP - GMP | 15522951 | GSE1584_DOC |
| 27_RA_RMA_Jan04_time_course | 15466718 | GSE1588_DOC |
| Whole brain gene expression in X-monosomic and normal female mice | 15908953 | GSE1606_DOC |
| Transcriptome of Ts1Cje and euploids cerebellum | 15590701 | GSE1611_DOC |
| Differential expression of genes after 48 hrs, 10 d, and 3 wks of TAC | 15292486 | GSE1621_DOC |
| NOD.scid, NOD, BDC2.5/NOD and BDC2.5/NOD.scid mice | 15671250 | GSE1623_DOC |
| Murine orofacial development | | GSE1624_DOC |
| Time series of diabetes and exercise training induced expression changes in skeletal muscle of mice | 16352670 | GSE1659_DOC |
| BPH and BPL mouse strain adrenal glands | 15882546 | GSE1674_DOC |
| Effect of CCL3 on target ablation-induced macrophage recruitment into the olfactory epithelium | 15467013 | GSE1680_DOC |
| Comparison of transcriptional changes in Cre infected with Vector infected alpha4-floxed MEFs | | GSE1708_DOC |
| Isolation and angiogenesis by endothelial progenitors in the fetal liver | 16099996 | GSE1727_DOC |
| Preimplantation mouse embryo development MOE430A | 15282163 | GSE1744_DOC |
| Preimplantation mouse embryo development MOE430B | 15282163 | GSE1745_DOC |
| Preimplantation mouse embryo development | 15282163 | GSE1749A_DOC |
| Preimplantation mouse embryo development | 15282163 | GSE1749B_DOC |
| Preimplantation mouse embryo development | 15282163 | GSE1749C_DOC |
| Soleus muscle | 16199803 | GSE1772_DOC |
| Control and starved myotubes | 15608089 | GSE1776_DOC |
| Effect of Neuromedin U on gene expression in murine T cells | 15585845 | GSE1791_DOC |
| Murine Spastic Spinal Cord | | GSE1800_DOC |
| Skeletal muscle allotypes | | GSE1806_DOC |
| Cardiac grafts pteridine cyclosporinA and NIL treated | 16495807 | GSE1809_DOC |
| response to HDI | 15885264 | GSE1811_DOC |
| Induction of similar multistage transcriptional responses in the mouse uterus by E2 and GEN | 15289156 | GSE1819_DOC |
| Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | | GSE1830A_DOC |
| Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | | GSE1830B_DOC |
| Myocilin effect on retina. Russell-7U24NS043571-02 | | GSE1835_DOC |
| Equivalence of biologic responses induced in the mouse uterus by E2, GEN, and DES | 15289156 | GSE1839_DOC |
| Boswellia Serrata | 15539433 | GSE1847_DOC |
| Fibrillin-1 deficient mice | 15546004 | GSE1852_DOC |
| mouse corneal stromal cells | 15452052 | GSE1867_DOC |
| SCCOR_MouseLung_Simva_LPS | 15665042 | GSE1871_DOC |
| The effect of intermittent hypoxia on gene expression in the liver of ob/ob mice | 16037401 | GSE1873_DOC |